Cassava Sciences is nearing a Phase 3 readout for its Alzheimer's drug, lecanemab, despite facing a scandal involving the SEC. Learn more about the latest updates on donanemab and the company's ...

People movements at GWEC, EnergyCo, Iberdrola, CEC, CS Energy, NHOA, Synergy, Squadron, Quinbrook, WFF, ACF, BYD, Fortescue, Western Power, Vattenfall, TCL Solar.

Infosecurity Magazine is the award winning online magazine dedicated to the strategy, insight and technology of information security ...